Cytogen (XKRX:217330) Other Long-Term Liabilities : ₩4,851 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cytogen Other Long-Term Liabilities?

Cytogen's other long-term liabilities for the quarter that ended in Mar. 2024 was ₩4,851 Mil.

Cytogen's quarterly other long-term liabilities declined from Sep. 2023 (₩1,438 Mil) to Dec. 2023 (₩1,271 Mil) but then increased from Dec. 2023 (₩1,271 Mil) to Mar. 2024 (₩4,851 Mil).

Cytogen's annual other long-term liabilities declined from Dec. 2021 (₩4,635 Mil) to Dec. 2022 (₩1,390 Mil) and declined from Dec. 2022 (₩1,390 Mil) to Dec. 2023 (₩1,271 Mil).

Cytogen Other Long-Term Liabilities Historical Data

The historical data trend for Cytogen's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Other Long-Term Liabilities Chart

Cytogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Cytogen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cytogen Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cytogen Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cytogen's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytogen (XKRX:217330) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854

Website

http://www.cytogenlab.com

Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines